-
Guizhou national medicine miao medicine development of new products continue
Time of Update: 2020-07-08
Guizhou National Pharmaceutical Company developed a new drug, "Mi-Heart-le-drip pills" recently successfully completed a clinical study, which marks the Guizhou Miao medicine in the treatment of car
-
New drug for Gao Xue's disease enters phase II clinical phase
Time of Update: 2020-07-08
genz-112638, a new oral drug developed by Genzyme for the treatment of the rare genetic disease Gaucher, is now in Phase II clinical phase Genzyme has published the data it obtained in Phase II clin
-
HUYA is licensed by Sidabenamine anti-tumor combination drug
Time of Update: 2020-07-08
HUYA Biosciences International,LLC announced on March 6 that it has obtained a global exclusive license from Shenzhen Microcore Biotech Co., Ltd for the anti- tumor combination drug chidamide (chi
-
New drugs for the treatment of AIDS in Yunnan Province complete clinical trials
Time of Update: 2020-07-08
Yunnan Province in recent years targeted research and development of a number of new drugs to treat AIDS, some drug has completed clinical trials, will be declared "new drug certificate" on the ma
-
There are new options for chronic hepatitis B treatment
Time of Update: 2020-07-08
recently, at the "Conquering the New Choice of Hepatitis B" academic conference held in Shanghai by Schering Yuya Pharmaceutical Company, Professor Cheng Jun, Vice Chairman of the Association of In
-
New TB vaccine expected to fight drug-resistant TB bacteria
Time of Update: 2020-07-08
The Aeras Global TB Vaccine Foundation said at the Global Health International Conference in Washington, D.C they and their partners are developing a new generation of TB vaccine hope to fight a
-
Israeli scientists develop miniature heart to treat heart disease
Time of Update: 2020-07-08
, researchers at the Israel Institute of Technology used embryonic stem cells to generate heart cells , endothelial cells and fibroblasts, and then implanted them in biodegradable structures After
-
Ukraine successfully developed the world's first "invention zipper"
Time of Update: 2020-07-08
, an engineer in Ukraine recently developed a "wound zipper" , has begun animal testing in Israel The product "creative zipper" can be said to be the world's first This "wound zipper", which is m
-
FDA approves new drug for high blood pressure
Time of Update: 2020-07-08
the U.S Food and Drug Administration approved the of Novartis , Switzerland, to develop a new drug for the treatment of hypertension Tekturna , this is the first renin inhibitor hypertension
-
U.S. approves new drug for advanced breast cancer
Time of Update: 2020-07-08
the U.S Food and Drug Administration on Thursday approved a new drug for advanced breast cancer, Tykerb, to be marketed, which will provide a new type of targeted therapy for patients with advanced
-
Japanese scientists develop new vaccine that says it could cure Alzheimer's disease
Time of Update: 2020-07-08
Alzheimer's disease is a common disease in the elderly, and amyloid protein is its cause Recently, a team of researchers such as the National Longevity Medical Center of Japan and Nagoya University
-
Complex triple yellow capsule completes clinical trial
Time of Update: 2020-07-08
recently, Yunnan Province independently developed a new anti-AIDS drug "complex three yellow capsules" completed clinical trial research work, and in February in Beijing University, the first hospi
-
British researchers develop new cancer treatment
Time of Update: 2020-07-08
develop a new cancer drug for cancer-related gene expression and have found a new method that could be used in prostate cancer testing The new drug, called HXR9, developed by researchers at the Uni
-
Third generation of professional antioxidants
Time of Update: 2020-07-08
recently, the Canadian National Institute of Integrated Medical Research and the China International Institute of Preventive Medicine jointly conducted an antioxidant research breakthrough Using the
-
Erbitux is expected to be a first-line drug against head and neck cancer
Time of Update: 2020-07-08
, U.S biopharmaceutical companies ImClone and Persimmon squipbo recently released the results of Phase III clinical studies using the monoantinodrug Erbitux and chemotherapy drug ligand The results s
-
The National Nanopharmaceutical Research Center has passed the feasibility demonstration
Time of Update: 2020-07-08
recently , the Ministry of Science and Technology of organized experts in the field of nanomedicine and engineering technology research center management experts , in Changsha, Hunan Province to s
-
U.S. scientists say a drug could extend the life span of liver cancer patients
Time of Update: 2020-07-08
liver cancer is a hard-to-cure cancer, with 600,000 people diagnosed with it every year, but the medical community has long lacked drugs to treat it effectively Recently, U.S scientists announced th
-
Chongqing successfully developed a digital eye tracker system to treat eye diseases
Time of Update: 2020-07-08
learned from the Chongqing Science and Technology Commission , a digital eye movement based on eye image analysis has been developed by the Southwest Hospital Doctors will analyze the of a pati
-
Breakthrough discovery in domestic contraceptive vaccine research
Time of Update: 2020-07-08
, a team of researchers at the Third Military Medical University recently discovered a new type of conosin- and hyper-activated calcium-binding protein (FSCB) involved in sperm exercise The finding
-
Ultra-light cooling suit developed in Switzerland for patients with multiple sclerosis
Time of Update: 2020-07-08
The Swiss Federal Laboratory for Materials Testing and Research (EMPA) recently announced that it has developed ultra-light cooling suits for people with multiple sclerosis This set of cooling suit
